
Neurological Devices Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Neurovascular Catheters, Neuromodulation Devices, and 12 more
- Year: 2022
- Scope: 10 Years
- Region: United States
- Pages: 432
- Published Date: 09/09/2022
- Type: MedSuite
In 2021, the U.S. neurological devices market size was valued at $5.8 billion. Moving forwards, the market size is expected to increase at a growth rate of 5.9% to reach $8.6 billion in 2028.
The full report suite on the U.S. market for neurological devices includes cerebrospinal fluid management, detachable coils, liquid embolics, neurovascular catheters, neurovascular guidewires, neurovascular stents, balloon occlusion devices, aneurysm clips, neurovascular thrombus management, neuromodulation devices, intrathecal pumps, stereotactic devices,neuroendoscopes and ultrasonic aspirators.
Market Data Included – U.S. Neurological Device MedSuite
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2027, and Historical Data to 2017
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
U.S. Neurological Device Market Insights
Neuromodulation devices comprise the largest segment for neurological devices, divided between several competitors in the spinal cord stimulation and deep brain stimulation space. Most other
segments, including vagus nerve stimulation, gastric electric stimulation, dorsal root ganglion stimulation and responsive neurostimulation, remain monopolized market segments at the time
of publication.
U.S. Neurological Device Market Share Insights
Medtronic has maintained its leading position in the neurological device market, but growing competition has broken several of its monopolies across the market. Across the company’s vast
product catalogue, it now only maintains a monopoly in the gastric electric stimulation market, with new competition working through the FDA approval process. Within the liquid embolic, intrathecal
pump and stereotactic device markets, Medtronic still holds more than half of the market share.
MARKET SEGMENTATION SUMMARY
The analyses on each of the following markets can be purchased as separate reports, MedCores.
- Cerebrospinal Fluid Management Market
- Detachable Coils Market
- Liquid Embolics Market
- Neurovascular Catheters Market
- Neurovascular Guidewires Market
- Neurovascular Catheter Market
- Neurovascular Stents Market
- Balloon Occlusion Device Market
- Aneurysm Clips Market
- Neurovascular Thrombus Management Market
- Neuromodulation Devices Market
- Intrathecal Pumps Market
- Stereotactic Devices Market
- Neuroendoscope Market
- Ultrasonic Aspirators Market
RESEARCH SCOPE SUMMARY
Report Attribute | Details |
---|---|
Region | North America (United States) |
Base Year | 2021 |
Forecast | 2022-2028 |
Historical Data | 2018-2021 |
Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
DON’T SEE THE SEGMENT OR DATA YOU NEED?
Feel free to contact us or send a request by pressing one of the buttons below.
TABLE OF CONTENTS I |
LIST OF FIGURES XIV |
LIST OF CHARTS XXIII |
EXECUTIVE SUMMARY 1 |
U S NEUROLOGICAL DEVICE MARKET OVERVIEW 1 |
COMPETITIVE ANALYSIS 3 |
MARKET TRENDS 6 |
MARKET DEVELOPMENTS 8 |
PROCEDURE NUMBERS 9 |
MARKETS INCLUDED 10 |
KEY REPORT UPDATES 12 |
VERSION HISTORY 12 |
RESEARCH METHODOLOGY 13 |
Step 1: Project Initiation & Team Selection 13 |
Step 2: Prepare Data Systems and Perform Secondary Research 16 |
Step 3: Preparation for Interviews & Questionnaire Design 18 |
Step 4: Performing Primary Research 19 |
Step 5: Research Analysis: Establishing Baseline Estimates 21 |
Step 6: Market Forecast and Analysis 22 |
Step 7: Identify Strategic Opportunities 24 |
Step 8: Final Review and Market Release 25 |
Step 9: Customer Feedback and Market Monitoring 26 |
IMPACT OF COVID-19 ON THE U S NEUROLOGICAL DEVICE MARKET 27 |
INTRODUCTION 27 |
ANALYSIS BY MARKET SEGMENT 29 |
Worst Case Scenario 29 |
Base Case Scenario 32 |
Best Case Scenario 35 |
DISEASE OVERVIEW 39 |
BASIC ANATOMY 39 |
DISEASE PATHOLOGY AND DISORDERS 41 |
Introduction 41 |
General Diagnostics and Neurosurgery 43 |
Tumor and Brain Cancer 45 |
Brain Arteriovenous Malformations 46 |
Ischemic Stroke 47 |
Brain Aneurysm 48 |
Disorders Related to Cerebrospinal Fluids and Intracranial Pressure 50 |
Hydrocephalus and Intracranial Pressure Disorder 50 |
Cerebral Edema 52 |
Indication for Neuromodulation 53 |
Traumatic Brain injury 55 |
PRODUCT ASSESSMENT 56 |
INTRODUCTION 56 |
PRODUCT PORTFOLIOS 56 |
Cerebrospinal Fluid Management 56 |
Detachable Coils 60 |
Liquid Embolics 62 |
Neurovascular Catheters 64 |
Neurovascular Guidewires 66 |
Neurovascular Stents 68 |
Balloon Occlusion Devices 70 |
Aneurysm Clip 72 |
Neurovascular Thrombus Management 74 |
Neuromodulation Devices 77 |
Introduction 77 |
Spinal Cord Stimulators 77 |
Vagus Nerve Stimulators 78 |
Deep Brain Stimulators 78 |
Gastric Electric Stimulators 78 |
Sacral Nerve Stimulators 79 |
Dorsal Root Ganglion Stimulation Market 80 |
Responsive Neurostimulation Market 80 |
Intrathecal Pumps 82 |
Stereotactic Devices 84 |
Neuroendoscopy Devices 87 |
Ultrasonic Aspiration Devices 90 |
REGULATORY ISSUES AND RECALLS 91 |
Cerebrospinal Fluid Management 91 |
Detachable Coils 92 |
Neurovascular Catheters 94 |
Neurovascular Stent 95 |
Balloon Occlusion Devices 96 |
Neuromodulation Devices 98 |
Neuroendoscopy 99 |
Stereotactic Devices 100 |
Ultrasonic Aspiration 102 |
Neurological Microscopes 103 |
Intrathecal Pumps 104 |
Mechanical Thrombectomy 105 |
CLINICAL TRIALS 106 |
Cerebrospinal Fluid Management 107 |
Detachable Coils 109 |
Liquid Embolics 111 |
Neurovascular Catheters 113 |
Neurovascular Guidewires 115 |
Neurovascular Stent 116 |
Neuromodulation devices 118 |
Neuroendoscopy 120 |
Stereotactic Devices 121 |
Ultrasonic Aspiration 123 |
Aneurysm Clip 125 |
Neurological Microscopes 126 |
Mechanical Thrombectomy 127 |
U S NEUROLOGICAL DEVICE MARKET OVERVIEW 128 |
INTRODUCTION 128 |
Cerebrospinal Fluid Management 128 |
Interventional Neuroradiology 128 |
Neuromodulation 129 |
Neurosurgery 130 |
Neurovascular Thrombectomy 131 |
MARKET OVERVIEW & TREND ANALYSIS 132 |
DRIVERS AND LIMITERS 138 |
Market Drivers 138 |
Cerebrospinal Fluid Management 138 |
Interventional Neuroradiology 138 |
Neuromodulation 139 |
Neurosurgery 140 |
Neurovascular Thrombectomy 141 |
Market Limiters 142 |
Cerebrospinal Fluid Management 142 |
Interventional Neuroradiology 142 |
Neuromodulation 142 |
Neurosurgery 143 |
Neurovascular Thrombectomy 144 |
COMPETITIVE MARKET SHARE ANALYSIS 145 |
MERGERS AND ACQUISITIONS 154 |
COMPANY PROFILES 155 |
Abbott 155 |
B Braun 156 |
Boston Scientific 157 |
Cerenovus 158 |
Integra LifeSciences 159 |
Codman & Shurtleff 159 |
LivaNova 160 |
Medtronic 161 |
MicroVention 162 |
Mizuho 163 |
Stryker 164 |
SWOT ANALYSIS 165 |
Abbott 166 |
B Braun 167 |
Boston Scientific 168 |
Integra LifeSciences 169 |
LivaNova 170 |
Medtronic 171 |
MicroVention 172 |
Mizuho 173 |
Stryker 174 |
PROCEDURE NUMBERS 175 |
PROCEDURE ANALYSIS AND FORECAST 175 |
Cerebrospinal Fluid Shunting Procedures 178 |
Interventional Treatment of Saccular Aneurysm Procedures 180 |
Liquid Embolization of AVM Procedures 182 |
Neurovascular Thrombus Management Procedures 183 |
Neuromodulation Procedures 185 |
Spinal Cord Stimulation Procedures 188 |
Deep Brain Stimulation Procedures 189 |
Intrathecal Pump Procedures 190 |
Stereotactic Surgery Procedures 192 |
Ultrasonic Aspiration Procedures 193 |
CEREBROSPINAL FLUID MANAGEMENT MARKET 194 |
INTRODUCTION 194 |
MARKET OVERVIEW 196 |
MARKET ANALYSIS AND FORECAST 199 |
Cerebrospinal Fluid Shunt Market 199 |
Adjustable Pressure Cerebrospinal Fluid Shunt Market 202 |
Fixed Pressure Cerebrospinal Fluid Shunt Market 204 |
Cerebrospinal Fluid External Drainage System Market 206 |
Ventricular Drainage System Market 208 |
Lumbar and Ventricular Drainage System Market 210 |
DRIVERS AND LIMITERS 211 |
Market Drivers 211 |
Market Limiters 212 |
COMPETITIVE MARKET SHARE ANALYSIS 214 |
DETACHABLE COIL MARKET 219 |
INTRODUCTION 219 |
MARKET OVERVIEW 220 |
MARKET ANALYSIS AND FORECAST 223 |
Total Detachable Coil Market 223 |
Bare Platinum Detachable Coil Market 224 |
Coated Detachable Coil Market 225 |
DRIVERS AND LIMITERS 226 |
Market Drivers 226 |
Market Limiters 227 |
COMPETITIVE MARKET SHARE ANALYSIS 229 |
LIQUID EMBOLIC MARKET 233 |
INTRODUCTION 233 |
MARKET ANALYSIS AND FORECAST 234 |
DRIVERS AND LIMITERS 236 |
Market Drivers 236 |
Market Limiters 236 |
COMPETITIVE MARKET SHARE ANALYSIS 238 |
NEUROVASCULAR CATHETER MARKET 241 |
INTRODUCTION 241 |
MARKET OVERVIEW 243 |
MARKET ANALYSIS AND FORECAST 246 |
Over-the-Wire Microcatheter Market 246 |
Flow-Directed Microcatheter Market 248 |
Neurovascular Guiding Catheter Market 250 |
DRIVERS AND LIMITERS 252 |
Market Drivers 252 |
Market Limiters 253 |
COMPETITIVE MARKET SHARE ANALYSIS 254 |
NEUROVASCULAR GUIDEWIRE MARKET 258 |
INTRODUCTION 258 |
MARKET ANALYSIS AND FORECAST 259 |
DRIVERS AND LIMITERS 262 |
Market Drivers 262 |
Market Limiters 262 |
COMPETITIVE MARKET SHARE ANALYSIS 264 |
NEUROVASCULAR STENT MARKET 268 |
INTRODUCTION 268 |
MARKET OVERVIEW 270 |
MARKET ANALYSIS AND FORECAST 272 |
Traditional Neurovascular Stent Market 272 |
Flow Diversion Stent Market 273 |
Intrasaccular Stent Market 274 |
DRIVERS AND LIMITERS 276 |
Market Drivers 276 |
Market Limiters 278 |
COMPETITIVE MARKET SHARE ANALYSIS 279 |
BALLOON OCCLUSION DEVICE MARKET 283 |
INTRODUCTION 283 |
MARKET ANALYSIS AND FORECAST 284 |
DRIVERS AND LIMITERS 286 |
Market Drivers 286 |
Market Limiters 286 |
COMPETITIVE MARKET SHARE ANALYSIS 288 |
ANEURYSM CLIP MARKET 291 |
INTRODUCTION 291 |
MARKET ANALYSIS AND FORECAST 293 |
Total Aneurysm Clip Market 293 |
Aneurysm Clip Market by Indication 295 |
Temporary Aneurysm Clip Market 296 |
Permanent Aneurysm Clip Market 297 |
Aneurysm Clip Market by Material 298 |
Titanium Aneurysm Clip Market 299 |
Cobalt Alloy Aneurysm Clip Market 300 |
DRIVERS AND LIMITERS 301 |
Market Drivers 301 |
Market Limiters 302 |
COMPETITIVE MARKET SHARE ANALYSIS 303 |
NEUROVASCULAR THROMBUS MANAGEMENT MARKET 307 |
INTRODUCTION 307 |
MARKET OVERVIEW 309 |
MARKET ANALYSIS AND FORECAST 312 |
Stent Retriever Market 312 |
Aspiration Catheter Market 313 |
DRIVERS AND LIMITERS 314 |
Market Drivers 314 |
Market Limiters 315 |
COMPETITIVE MARKET SHARE ANALYSIS 316 |
NEUROMODULATION DEVICE MARKET 320 |
INTRODUCTION 320 |
Spinal Cord Stimulation 320 |
Deep Brain Stimulation 321 |
Sacral Nerve Stimulation 322 |
Vagus Nerve Stimulation 323 |
Gastric Electric Stimulation 323 |
Dorsal Root Ganglion Stimulation 324 |
Responsive Neurostimulation 325 |
MARKET OVERVIEW 326 |
MARKET ANALYSIS AND FORECAST 329 |
Spinal Cord Stimulation Market 329 |
Spinal Cord Stimulation Generator Market by Battery Type 332 |
Rechargeable Spinal Cord Stimulation Generator Market 334 |
Non-Rechargeable Spinal Cord Stimulation Generator Market 335 |
Spinal Cord Stimulation Generator Market by Channel Type 336 |
Dual-Channel Spinal Cord Stimulation Generator Market 338 |
Tri & Quad-Channel Spinal Cord Stimulation Generator Market 339 |
Spinal Cord Stimulation Lead Market 340 |
Percutaneous Lead Market 342 |
Paddle and Surgical Lead Market 343 |
Spinal Cord Stimulation Implants by Application 344 |
Deep Brain Stimulation Market 345 |
Sacral Nerve Stimulation Market 346 |
Sacral Nerve Stimulation Generator Market by Battery Type 347 |
Rechargeable Sacral Nerve Stimulation Generator Market 349 |
Non-Rechargeable Sacral Nerve Stimulation Generator Market 350 |
Vagus Nerve Stimulation Market 351 |
Gastric Electric Stimulation Market 353 |
Dorsal Root Ganglion Stimulation Market 354 |
Responsive Neurostimulation Device Market 355 |
DRIVERS AND LIMITERS 356 |
Spinal Cord Stimulation Market 356 |
Market Drivers 356 |
Market Limiters 357 |
Deep Brain Stimulation Market 358 |
Market Drivers 358 |
Market Limiters 358 |
Sacral Nerve Stimulation Market 359 |
Market Drivers 359 |
Market Limiters 360 |
Vagus Nerve Stimulation Market 361 |
Market Drivers 361 |
Market Limiters 361 |
Gastric Electric Stimulation Market 362 |
Market Drivers 362 |
Market Limiters 362 |
Dorsal Root Ganglion Stimulation Market 363 |
Market Drivers 363 |
Market Limiters 363 |
Responsive Neurostimulation Device Market 364 |
Market Drivers 364 |
Market Limiters 364 |
COMPETITIVE MARKET SHARE ANALYSIS 366 |
INTRATHECAL PUMP MARKET 372 |
INTRODUCTION 372 |
MARKET ANALYSIS AND FORECAST 374 |
DRIVERS AND LIMITERS 377 |
Market Drivers 377 |
Market Limiters 378 |
COMPETITIVE MARKET SHARE ANALYSIS 379 |
STEREOTACTIC DEVICE MARKET 382 |
INTRODUCTION 382 |
MARKET OVERVIEW 384 |
MARKET ANALYSIS AND FORECAST 387 |
Frame-Based Stereotactic Device Market 387 |
Frameless Stereotactic Device Market 388 |
INSTALLED BASE ANALYSIS 389 |
Frame-Based Stereotactic Device Market 389 |
Frameless Stereotactic Device Market 390 |
DRIVERS AND LIMITERS 391 |
Market Drivers 391 |
Market Limiters 392 |
COMPETITIVE MARKET SHARE ANALYSIS 394 |
NEUROENDOSCOPY MARKET 399 |
INTRODUCTION 399 |
MARKET OVERVIEW 401 |
MARKET ANALYSIS AND FORECAST 404 |
Rigid Endoscope Market 404 |
Flexible Endoscope Market 405 |
Videoscope Market 406 |
Single-Use Endoscope Market 407 |
Neuroendoscopic Hand Instrument Market 408 |
Neuroendoscopy Disposables Market 409 |
DRIVERS AND LIMITERS 410 |
Market Drivers 410 |
Market Limiters 411 |
COMPETITIVE MARKET SHARE ANALYSIS 413 |
ULTRASONIC ASPIRATOR MARKET 417 |
INTRODUCTION 417 |
MARKET OVERVIEW 418 |
MARKET ANALYSIS AND FORECAST 420 |
Capital Equipment Market 420 |
Installed Base 421 |
Disposable Probe Tip Market 422 |
Disposable Tubing Market 423 |
DRIVERS AND LIMITERS 424 |
Market Drivers 424 |
Market Limiters 425 |
COMPETITIVE MARKET SHARE ANALYSIS 426 |
APPENDIX: INTRACEREBRAL HEMORRHAGE TREATMENT 429 |
INTRODUCTION 429 |
MARKET DRIVERS 431 |
ABBREVIATIONS 432 |
- Medtronic
- Abbott
- Stryker
- Boston Scientific
- LivaNova
- Nevro
- MicroVention
- Penumbra
- Integra LifeSciences
- Cerenovus
- Axonics
- Brainlab
- NeuroPace
- Aesculap
- Mizuho
- Q’apel Medical
- Elekta
- Karl Storz
Chart 1-1: Neurological Device Market by Segment, U S , 2021 – 2028 2 |
Chart 1-2: Neurological Device Market Overview, U S , 2021 & 2028 2 |
Chart 2-1: Multi-Scenario Neurological Device Market Forecast, U S , 2018 – 2028 (US$M) 38 |
Chart 5-1: Neurological Device Market by Segment, U S , 2018 – 2028 137 |
Chart 5-2: Leading Competitors, Neurological Device Market, U S , 2021 153 |
Chart 6-1: Neurological Procedures by Type, U S , 2018 – 2028 177 |
Chart 7-1: Cerebrospinal Fluid Management Market by Segment, U S , 2018 – 2028 198 |
Chart 7-2: Leading Competitors, Cerebrospinal Fluid Management Market, U S , 2021 218 |
Chart 8-1: Detachable Coil Market by Segment, U S , 2018 – 2028 222 |
Chart 8-2: Leading Competitors, Detachable Coil Market, U S , 2021 232 |
Chart 9-1: Liquid Embolic Market, U S , 2018 – 2028 235 |
Chart 9-2: Leading Competitors, Liquid Embolic Market, U S , 2021 240 |
Chart 10-1: Neurovascular Catheter Market by Segment, U S , 2018 – 2028 245 |
Chart 10-2: Leading Competitors, Neurovascular Catheter Market, U S , 2021 257 |
Chart 11-1: Neurovascular Guidewire Market, U S , 2018 – 2028 261 |
Chart 11-2: Leading Competitors, Neurovascular Guidewire Market, U S , 2021 267 |
Chart 12-1: Neurovascular Stent Market by Segment, U S , 2018 – 2028 271 |
Chart 12-2: Leading Competitors, Neurovascular Stent Market, U S , 2021 282 |
Chart 13-1: Balloon Occlusion Device Market, U S , 2018 – 2028 285 |
Chart 13-2: Leading Competitors, Balloon Occlusion Device Market, U S , 2021 290 |
Chart 14-1: Leading Competitors, Aneurysm Clip Market, U S , 2021 306 |
Chart 15-1: Neurovascular Thrombectomy Market by Segment, U S , 2018 – 2028 311 |
Chart 15-2: Leading Competitors, Neurovascular Thrombus Management Market, U S , 2021 319 |
Chart 16-1: Neuromodulation Device Market by Segment, U S , 2018 – 2028 328 |
Chart 16-2: Leading Competitors, Neuromodulation Device Market, U S , 2021 371 |
Chart 17-1: Intrathecal Pump Market, U S , 2018 – 2028 376 |
Chart 17-2: Leading Competitors, Intrathecal Pump Market, U S , 2021 381 |
Chart 18-1: Stereotactic Device Market by Segment, U S , 2018 – 2028 386 |
Chart 18-2: Leading Competitors, Stereotactic Device Market, U S , 2021 398 |
Chart 19-1: Neuroendoscopy Market by Segment, U S , 2018 – 2028 403 |
Chart 19-2: Leading Competitors, Neuroendoscopy Market, U S , 2021 416 |
Chart 20-1: Ultrasonic Aspirator Market by Segment, U S , 2018 – 2028 419 |
Chart 20-2: Leading Competitors, Ultrasonic Aspirator Market, U S , 2021 428 |
Figure 1-1: Neurological Device Market Share Ranking by Segment, U S , 2021 (1 of 2) 4 |
Figure 1-2: Neurological Device Market Share Ranking by Segment, U S , 2021 (2 of 2) 4 |
Figure 1-3: Companies Researched in this Report, U S , 2021 5 |
Figure 1-4: Factors Impacting the Neurological Device Market by Segment, U S (1 of 2) 6 |
Figure 1-5: Factors Impacting the Neurological Device Market by Segment, U S (2 of 2) 7 |
Figure 1-6: Recent Events in the Neurological Device Market, U S , 2018 – 2021 8 |
Figure 1-1: Neurological Device Procedures Covered 9 |
Figure 1-2: Neurological Device Markets Covered (1 of 2) 10 |
Figure 1-3: Neurological Device Markets Covered (2 of 2) 11 |
Figure 1-4: Key Report Updates 12 |
Figure 1-5: Version History 12 |
Figure 2-1: Neurological Device Market by Segment, Worst Case Scenario, U S , 2018 – 2028 (US$M) (1 of |
3) 29 |
Figure 2-2: Neurological Device Market by Segment, Worst Case Scenario, U S , 2018 – 2028 (US$M) (2 of |
3) 30 |
Figure 2-3: Neurological Device Market by Segment, Worst Case Scenario, U S , 2018 – 2028 (US$M) (3 of |
3) 31 |
Figure 2-4: Neurological Device Market by Segment, Base Case Scenario, U S , 2018 – 2028 (US$M) (1 of |
3) 32 |
Figure 2-5: Neurological Device Market by Segment, Base Case Scenario, U S , 2018 – 2028 (US$M) (2 of |
3) 33 |
Figure 2-6: Neurological Device Market by Segment, Base Case Scenario, U S , 2018 – 2028 (US$M) (3 of |
3) 34 |
Figure 2-7: Neurological Device Market by Segment, Best Case Scenario, U S , 2018 – 2028 (US$M) (1 of |
3) 35 |
Figure 2-8: Neurological Device Market by Segment, Best Case Scenario, U S , 2018 – 2028 (US$M) (2 of |
3) 36 |
Figure 2-9: Neurological Device Market by Segment, Best Case Scenario, U S , 2018 – 2028 (US$M) (3 of |
3) 37 |
Figure 3-1: Neurology Disease Overview 42 |
Figure 4-1: Shunt Types 57 |
Figure 4-2: Cerebrospinal Fluid Management by Company 59 |
Figure 4-3: Detachable Coils by Company 61 |
Figure 4-4: Liquid Embolics by Company 63 |
Figure 4-5: Neurovascular Catheters by Company 65 |
Figure 4-6: Neurovascular Guidewires by Company 67 |
Figure 4-7: Neurovascular Stent by Company 69 |
Figure 4-8: Balloon Occlusion Devices by Company 71 |
Figure 4-9: Aneurysm Clip Devices by Company 73 |
Figure 4-10: Neurovascular Thrombus Management Devices by Company 76 |
Figure 4-11: Neuromodulation Devices by Company 81 |
Figure 4-12: Intrathecal Pumps Devices by Company 83 |
Figure 4-13: Stereotactic Devices by Company 86 |
Figure 4-14: Neuroendoscopy by Company 89 |
Figure 4-15: Ultrasonic Aspiration Devices by Company 90 |
Figure 4-16: Class 2 Device Recall Natus EDS3 CSF External Drainage System 91 |
Figure 4-17: Class 2 Device Recall Medtronic PS Medical CSFFlow Control Valves 91 |
Figure 4-18: Class 2 Device Recall MicroVention Terumo Microplex 10, Helical 10 Soft 92 |
Figure 4-19: Class 2 Device Recall MicroVention Terumo HydroFrame 10 and 18 92 |
Figure 4-20: Class 2 Device Recall MicroVention Terumo Microplex 10, Compass 10 92 |
Figure 4-21: Class 2 Device Recall MicroVention Terumo HydroSoft 10, HydroSoft 3D 93 |
Figure 4-22: Class 2 Device Recall GALAXY G3 Mini Microcoil Delivery System 93 |
Figure 4-23: Class 2 Device Recall C315HIS Delivery Catheter 94 |
Figure 4-24: Class 2 Device Recall MIVI Super 90 Guide Catheters 94 |
Figure 4-25:Class 2 Device Recall MAMBA Flex 135 Microcatheter 94 |
Figure 4-26: Class 2 Device Recall Intracranial Neurovascular Stent 95 |
Figure 4-27: Class 2 Device Recall MIVI Super 90 Guide Catheters 96 |
Figure 4-28: Class 2 Device Recall MAMBA Flex 135 Microcatheter 96 |
Figure 4-29:Class 2 Device Recall 6F Launcher Guide Catheter 96 |
Figure 4-30: Class 2 Device Recall Conquest PTA Balloon Dilatation Catheter 97 |
Figure 4-31:Class 2 Device Recall Merci Balloon Guide Catheters 97 |
Figure 4-32: Class 2 Device Recall Medtronic Wireless Recharger 98 |
Figure 4-33: Class 2 Device Recall Model B352000 Percept PC BrainSense Implantable Neurostimulator 98 |
Figure 4-34: Class 2 Device Recall A610 98 |
Figure 4-35: Class 2 Device Recall Percept PC Implantable Neurostimulator (INS) 98 |
Figure 4-36: Class 2 Device Recall KARL STORZ NEUROFIBERSCOPE 99 |
Figure 4-37: Class 2 Device Recall Karl Storz NeuroFiberscope 99 |
Figure 4-38: Class 2 Device Recall FLEXIBLE NEURO FIBERSCOPE 99 |
Figure 4-39: Class 2 Device Recall Stealth Autoguide Tracker, Model: 28248 100 |
Figure 4-40:Class 2 Device Recall Medtronic 100 |
Figure 4-41: Class 2 Device Recall Polaris Spectra Camera for StealthStation S7 System 100 |
Figure 4-42:Class 2 Device Recall Leksell Vantage Stereotactic System 100 |
Figure 4-43: Class 2 Device Recall Leksell Vantage Stereotactic System 101 |
Figure 4-44:Class 2 Device Recall ROSA Brain 3 0 Application Brain and ROSA One 3 1 101 |
Figure 4-45: Class 2 Device Recall Trident Endoscopic Ultrasonic Aspiration Needle (FNA) 102 |
Figure 4-46: Class 2 Device Recall Footswitch accessory 102 |
Figure 4-47: Class 2 Device Recall Leica M220 F12 103 |
Figure 4-48: Class 2 Device Recall Prometra Programmable Pump System 104 |
Figure 4-49: Class 2 Device Recall Medtronic Synchromed II Implantable Drug Infusion Pump 104 |
Figure 4-50: Class 2 Device Recall AXS Vecta 71 , Vecta 74 Aspiration Catheter 105 |
Figure 4-51: Class 1 Device Recall MINDFRAME CAPTURE(TM) LP Revascularization Device 105 |
Figure 4-52: Class 2 Device Recall Trevo XP ProVue System 105 |
Figure 4-53: The Effect of Lumbar CSF Drainage on the Neurologic Outcome Improvement in OHCA |
Underwent TTM 107 |
Figure 4-54: Operative Procedures vs Endovascular Neurosurgery for Untreated Pseudotumor Trial |
(OPEN-UP) 107 |
Figure 4-55: Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension |
(HYDROPTIC) 108 |
Figure 4-56: SMART - A Prospective, Multicenter Study Assessing the Embolization of Neurovascular |
Lesions Using the Penumbra Smart Coil 109 |
Figure 4-57: Prospective, Randomized, Controlled, Open Label, All China, Multi-Center, Registration Trial |
of the MICROPORT NEUROTECH Coil Embolization System for the Traetment of Intracranial Aneurysms |
109 |
Figure 4-58: Transcatheter Leak Closure with Detachable Coils Following Incomplete Left Atrial |
Appendage Closure Procedures (TREASURE) 110 |
Figure 4-59: Middle Meningeal Artery Embolization with Liquid Embolic Agent for Treatment of Chronic |
Subdural Hematoma 111 |
Figure 4-60: Treatment of Cerebral Arteriovenous Malformations with SQUID Liquid Embolic Agent - The |
CHOICE Study A Non-interventional, Prospective, Single-arm, International, Multicenter Study 111 |
Figure 4-61: quid Liquid Embolic Agent for the Embolization of Abdominopelvic Arterial Bleeding |
Syndrome (SQUIDperi Study) (SQUIDperi) 112 |
Figure 4-62: Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous |
Malformations 112 |
Figure 4-63: SMART - A Prospective, Multicenter Study Assessing the Embolization of Neurovascular |
Lesions Using the Penumbra Smart Coil 113 |
Figure 4-64: Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps |
for CSF Infusion 113 |
Figure 4-65: Inflammatory and Infectious Diseases of the Nervous System 114 |
Figure 4-66: Safety and Utility Profile of the Asahi Chikai Black 18 neurovascular guidewire in Large Vessel |
Occlusive Stroke: SURE 18 Registry 115 |
Figure 4-67: Evaluation of Safety and Performance of the Neuroform AtlasTM Stent System for |
Intracranial Aneurysm Treatment - Post Market Clinical Follow-up 116 |
Figure 4-68: Safety and Effectiveness of the Treatment of Wide Neck, Intracranial, Saccular Aneurysms |
with the Next Generation Neuroform Stent System 116 |
Figure 4-69: MicroNet-covered Stent System for Stroke Prevention in All Comer Carotid Revascularization |
(PARADIGM-EXT) 117 |
Figure 4-70: The Motor Network in Essential Tremor: Mechanisms of Therapy 118 |
Figure 4-71: Wearable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease (WAVE-AD) |
118 |
Figure 4-72: A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in |
Children and Adolescents Visiting the Emergency Department 119 |
Figure 4-73: Minimally-invasive Surgery Versus Craniotomy in Patients with Supratentorial Hypertensive |
Intracerebral Hemorrhage: A Multi-center Randomized Controlled Trial 120 |
Figure 4-74: Minimally Invasive Treatment of Hypertensive Basal Ganglia Hemorrhage by Transfrontal |
Keyhole Neuroendoscopy 120 |
Figure 4-75: Phase I Study of Stereotactic Radiosurgery Dose Escalation for Brain Metastases 121 |
Figure 4-76: Cyberknife Radiosurgery for Patients with Brain Metastases Diagnosed With Either SPACE or |
MPRAGE Sequence - A Prospective Randomized Evaluation of Response and Toxicity 121 |
Figure 4-77: Phase I TITE-CREM Dose Escalation Study of Fractionated Stereotactic Radiation Therapy |
(FSRT) in Unresected Brain Metastases 122 |
Figure 4-78: Safety and Effectiveness of SOFIA™/SOFIA™ PLUS for Direct Aspiration in Acute Ischemic |
Stroke (SESAME) 123 |
Figure 4-79: Feasibility Study of RapidPulseTM Aspiration System as Frontline Approach for Stroke |
Patients (RapidPulseFS) 123 |
Figure 4-80: A Single-Arm Objective Performance Criteria Trail For Intracranial Thrombus Aspiration |
Catheter 124 |
Figure 4-81: A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage |
Patients Undergoing Aneurysm Clipping 125 |
Figure 4-82: Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting |
and Preserving Terminated Nerve Ends 126 |
Figure 4-83: Regional Strategy for Transfer for Mechanical Thrombectomy (START) 127 |
Figure 4-84: Evaluation of Mechanical Thrombectomy in Acute Ischemic Stroke Related to a Distal |
Arterial Occlusion (DISCOUNT) 127 |
Figure 5-1: Neurological Device Market by Segment, U S , 2018 – 2028 (US$M) (1 of 3) 134 |
Figure 5-2: Neurological Device Market by Segment, U S , 2018 – 2028 (US$M) (2 of 3) 135 |
Figure 5-3: Neurological Device Market by Segment, U S , 2018 – 2028 (US$M) (3 of 3) 136 |
Figure 5-4: Leading Competitors, Neurological Device Market, U S , 2021 (1 of 3) 150 |
Figure 5-5: Leading Competitors, Neurological Device Market, U S , 2021 (2 of 3) 151 |
Figure 5-6: Leading Competitors, Neurological Device Market, U S , 2021 (3 of 3) 152 |
Figure 5-7: SWOT Analysis, Abbott 166 |
Figure 5-8: SWOT Analysis, B Braun 167 |
Figure 5-9 SWOT Analysis, Boston Scientific 168 |
Figure 5-10: SWOT Analysis, Integra LifeSciences 169 |
Figure 5-11: SWOT Analysis, LivaNova 170 |
Figure 5-12: SWOT Analysis, Medtronic 171 |
Figure 5-13: SWOT Analysis, MicroVention 172 |
Figure 5-14: SWOT Analysis, Mizuho 173 |
Figure 5-15: SWOT Analysis, Stryker 174 |
Figure 6-1: Neurological Procedures by Type, U S , 2018 – 2028 (1 of 2) 175 |
Figure 6-2: Neurological Procedures by Type, U S , 2018 – 2028 (2 of 2) 176 |
Figure 6-3: Cerebrospinal Fluid Shunting Procedures, U S , 2018 – 2028 179 |
Figure 6-4: Interventional treatment of Saccular Aneurysm Procedures by Modality, U S , 2018 – 2028 181 |
Figure 6-5: Liquid Embolization of AVM Procedures, U S , 2018 – 2028 182 |
Figure 6-6: Thrombus Management Procedures by Modality, U S , 2018 – 2028 184 |
Figure 6-7: Neuromodulation Implantation Procedures, U S , 2018 – 2028 (1 of 2) 186 |
Figure 6-8: Neuromodulation Implantation Procedures, U S , 2018 – 2028 (2 of 2) 187 |
Figure 6-9: Spinal Cord Stimulation Implantation Procedures, U S , 2018 – 2028 188 |
Figure 6-10: Deep Brain Stimulation Implantation Procedures, U S , 2018 – 2028 189 |
Figure 6-11: Intrathecal Pump Procedures, U S , 2018 – 2028 191 |
Figure 6-12: Stereotactic Surgery Procedures, U S , 2018 – 2028 192 |
Figure 6-13: Ultrasonic Aspiration Procedures, U S , 2018 – 2028 193 |
Figure 7-1: Cerebrospinal Fluid Management Market by Segment, U S , 2018 – 2028 (US$M) 197 |
Figure 7-2: Cerebrospinal Fluid Shunt Market by Segment, U S , 2018 – 2028 200 |
Figure 7-3: Total Cerebrospinal Fluid Shunt Market, U S , 2018 – 2028 201 |
Figure 7-4: Adjustable Pressure Cerebrospinal Fluid Shunt Market, U S , 2018 – 2028 203 |
Figure 7-5: Fixed Pressure Cerebrospinal Fluid Shunt Market, U S , 2018 – 2028 205 |
Figure 7-6: Cerebrospinal Fluid External Drainage System Market by Segment, U S , 2018 – 2028 206 |
Figure 7-7: Total Cerebrospinal Fluid External Drainage System Market, U S , 2018 – 2028 207 |
Figure 7-8: Ventricular Drainage System Market, U S , 2018 – 2028 209 |
Figure 7-9: Lumbar and Ventricular Drainage System Market, U S , 2018 – 2028 210 |
Figure 7-10: Leading Competitors, Cerebrospinal Fluid Management Market, U S , 2021 217 |
Figure 8-1: Detachable Coil Market by Segment, U S , 2018 – 2028 (US$M) 221 |
Figure 8-2: Total Detachable Coil Market, U S , 2018 – 2028 223 |
Figure 8-3: Bare Platinum Detachable Coil Market, U S , 2018 – 2028 224 |
Figure 8-4: Coated Detachable Coil Market, U S , 2018 – 2028 225 |
Figure 8-5: Leading Competitors, Detachable Coil Market, U S , 2021 231 |
Figure 9-1: Liquid Embolic Market, U S , 2018 – 2028 234 |
Figure 9-2: Leading Competitors, Liquid Embolic Market, U S , 2021 239 |
Figure 10-1: Neurovascular Catheter Market by Segment, U S , 2018 – 2028 244 |
Figure 10-2: Over-the-Wire Microcatheter Market, U S , 2018 – 2028 247 |
Figure 10-3: Flow-Directed Microcatheter Market, U S , 2018 – 2028 249 |
Figure 10-4: Neurovascular Guiding Catheter Market, U S , 2018 – 2028 251 |
Figure 10-5: Leading Competitors, Neurovascular Catheter Market, U S , 2021 256 |
Figure 11-1: Neurovascular Guidewire Market, U S , 2018 – 2028 260 |
Figure 11-2: Leading Competitors, Neurovascular Guidewire Market, U S , 2021 266 |
Figure 12-1: Neurovascular Stent Market by Segment, U S , 2018 – 2028 (US$M) 270 |
Figure 12-2: Traditional Neurovascular Stent Market, U S , 2018 – 2028 272 |
Figure 12-3: Flow Diversion Stent Market, U S , 2018 – 2028 273 |
Figure 12-4: Intrasaccular Stent Market, U S , 2018 – 2028 275 |
Figure 12-5: Leading Competitors, Neurovascular Stent Market, U S , 2021 281 |
Figure 13-1: Balloon Occlusion Device Market, U S , 2018 – 2028 284 |
Figure 13-2: Leading Competitors, Balloon Occlusion Device Market, U S , 2021 289 |
Figure 14-1: Total Aneurysm Clip Market, U S , 2018 – 2028 294 |
Figure 14-2: Aneurysm Clip Market by Indication, U S , 2018 – 2028 (US$M) 295 |
Figure 14-3: Temporary Aneurysm Clip Market, U S , 2018 – 2028 296 |
Figure 14-4: Permanent Aneurysm Clip Market, U S , 2018 – 2028 297 |
Figure 14-5: Aneurysm Clip Market by Material, U S , 2018 – 2028 (US$M) 298 |
Figure 14-6: Titanium Aneurysm Clip Market, U S , 2018 – 2028 299 |
Figure 14-7: Cobalt Alloy Aneurysm Clip Market, U S , 2018 – 2028 300 |
Figure 14-8: Leading Competitors, Aneurysm Clip Market, U S , 2021 304 |
Figure 14-9: Leading Competitors, Aneurysm Clip Market by Indication, U S , 2021 305 |
Figure 14-10: Leading Competitors, Aneurysm Clip Market by Material, U S , 2021 305 |
Figure 15-1: Neurovascular Thrombus Management Market by Segment, U S , 2018 – 2028 310 |
Figure 15-2: Stent Retriever Market, U S , 2018 – 2028 312 |
Figure 15-3: Aspiration Catheter Market, U S , 2018 – 2028 313 |
Figure 15-4: Leading Competitors, Neurovascular Thrombus Management Market, U S , 2021 318 |
Figure 16-1: Neuromodulation Device by Segment, U S , 2018 – 2028 (US$M) 327 |
Figure 16-2: Spinal Cord Stimulation Market by Segment, U S , 2018 – 2028 (US$M) 330 |
Figure 16-3: Total Spinal Cord Stimulation Market, U S , 2018 – 2028 331 |
Figure 16-4: Spinal Cord Stimulation Generator Market by Battery Type, U S , 2018 – 2028 (US$M) 333 |
Figure 16-5: Rechargeable Spinal Cord Stimulation Generator Market, U S , 2018 – 2028 334 |
Figure 16-6: Non-Rechargeable Spinal Cord Stimulation Generator Market, U S , 2018 – 2028 335 |
Figure 16-7: Spinal Cord Stimulation Generator Market by Channel Type, U S , 2018 – 2028 (US$M) 337 |
Figure 16-8: Dual-Channel Spinal Cord Stimulation Generator Market, U S , 2018 – 2028 338 |
Figure 16-9: Tri & Quad-Channel Spinal Cord Stimulation Generator Market, U S , 2018 – 2028 339 |
Figure 16-10: Spinal Cord Stimulation Lead Market, U S , 2018 – 2028 341 |
Figure 16-11: Percutaneous Lead Market, U S , 2018 – 2028 342 |
Figure 16-12: Paddle and Surgical Lead Market, U S , 2018 – 2028 343 |
Figure 16-13: Spinal Cord Stimulation Implants by Application, U S , 2021 344 |
Figure 16-14: Deep Brain Stimulation Market, U S , 2018 – 2028 345 |
Figure 16-15: Total Sacral Nerve Stimulation Market, U S , 2018 – 2028 346 |
Figure 16-16: Sacral Nerve Stimulation Generator Market by Battery Type, U S , 2018 – 2028 (US$M) 348 |
Figure 16-17: Rechargeable Sacral Nerve Stimulation Generator Market, U S , 2018 – 2028 349 |
Figure 16-18: Non-Rechargeable Sacral Nerve Stimulation Generator Market, U S , 2018 – 2028 350 |
Figure 16-19: Vagus Nerve Stimulation Market, U S , 2018 – 2028 352 |
Figure 16-20: Gastric Electric Stimulation Market, U S , 2018 – 2028 353 |
Figure 16-21: Dorsal Root Ganglion Stimulation Market, U S , 2018 – 2028 354 |
Figure 16-22: Responsive Neurostimulation Device Market, U S , 2018 – 2028 355 |
Figure 16-23: Leading Competitors, Neuromodulation Device Market, U S , 2021 370 |
Figure 17-1: Intrathecal Pump Market, U S , 2018 – 2028 375 |
Figure 17-2: Leading Competitors, Intrathecal Pump Market, U S , 2021 380 |
Figure 18-1: Stereotactic Device Market by Segment, U S , 2018 – 2028 385 |
Figure 18-2: Frame-Based Stereotactic Device Market, U S , 2018 – 2028 387 |
Figure 18-3: Frameless Stereotactic Device Market, U S , 2018 – 2028 388 |
Figure 18-4: Installed Base, Frame-Based Stereotactic Device Market, U S , 2018 – 2028 389 |
Figure 18-5: Installed Base, Frameless Stereotactic Device Market, U S , 2018 – 2028 390 |
Figure 18-6: Leading Competitors, Stereotactic Device Market, U S , 2021 397 |
Figure 19-1: Neuroendoscopy Market by Segment, U S , 2018 – 2028 402 |
Figure 19-2: Rigid Endoscope Market, U S , 2018 – 2028 404 |
Figure 19-3: Flexible Endoscope Market, U S , 2018 – 2028 405 |
Figure 19-4: Videoscope Market, U S , 2018 – 2028 406 |
Figure 19-5: Single-Use Endoscope Market, U S , 2018 – 2028 407 |
Figure 19-6: Neuroendoscopic Hand Instrument Market, U S , 2018 – 2028 408 |
Figure 19-7: Neuroendoscopy Disposables Market, U S , 2018 – 2028 409 |
Figure 19-8: Leading Competitors, Neuroendoscopy Market, U S , 2019 415 |
Figure 20-1: Ultrasonic Aspirator Market by Segment, U S , 2018 – 2028 418 |
Figure 20-2: Capital Equipment Market, U S , 2018 – 2028 420 |
Figure 20-3: Installed Base, Ultrasonic Aspirator Market, U S , 2018 – 2028 421 |
Figure 20-4: Leading Competitors, Ultrasonic Aspirator Market, U S , 2021 427 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
Report Summary | FREE |
Neurological Devices Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Neurovascular Catheters, Neuromodulation Devices, and 12 more
$7,995 – $9,995
iData’s U.S. neurology devices market MedSuite covers 14 markets and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.
- 2022
- 10 Years
- United States
- 09/09/2022
- 432
- MedSuite



